IN2014CN02163A - - Google Patents

Info

Publication number
IN2014CN02163A
IN2014CN02163A IN2163CHN2014A IN2014CN02163A IN 2014CN02163 A IN2014CN02163 A IN 2014CN02163A IN 2163CHN2014 A IN2163CHN2014 A IN 2163CHN2014A IN 2014CN02163 A IN2014CN02163 A IN 2014CN02163A
Authority
IN
India
Prior art keywords
endos49
igg
mutant
endos
seq
Prior art date
Application number
Other languages
English (en)
Inventor
Mattias Collin
Maria Allhorn
Jonathan Sjögren
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of IN2014CN02163A publication Critical patent/IN2014CN02163A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN2163CHN2014 2011-09-13 2012-09-12 IN2014CN02163A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (1)

Publication Number Publication Date
IN2014CN02163A true IN2014CN02163A (es) 2015-05-29

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2163CHN2014 IN2014CN02163A (es) 2011-09-13 2012-09-12

Country Status (20)

Country Link
US (1) US9493752B2 (es)
EP (1) EP2756077B1 (es)
JP (1) JP6076349B2 (es)
KR (1) KR102001427B1 (es)
CN (1) CN103946377B (es)
AU (1) AU2012307461B2 (es)
BR (1) BR112014005816A2 (es)
CA (1) CA2848230C (es)
DK (1) DK2756077T3 (es)
EA (1) EA028490B8 (es)
ES (1) ES2627334T3 (es)
GB (2) GB201115841D0 (es)
IL (1) IL231410A0 (es)
IN (1) IN2014CN02163A (es)
MX (1) MX347727B (es)
PL (1) PL2756077T3 (es)
PT (1) PT2756077T (es)
SG (1) SG11201400505YA (es)
WO (1) WO2013037824A1 (es)
ZA (1) ZA201401840B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398677T1 (de) * 2000-12-21 2008-07-15 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
EP2911699B1 (en) 2012-10-23 2017-11-15 SynAffix B.V. Modified antibody, antibody-conjugate and process for the preparation thereof
EP3613468A1 (en) 2013-05-02 2020-02-26 Glykos Finland Oy Glycoprotein-toxic payload conjugates
EP2935611B1 (en) 2013-10-14 2021-07-07 SynAffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
CN105814213B (zh) 2013-10-14 2021-05-04 西纳福克斯股份有限公司 经修饰的糖蛋白、蛋白质-缀合物及其制备方法
US20160235861A1 (en) 2013-10-14 2016-08-18 SynAffix. B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
CN106660967A (zh) 2014-01-24 2017-05-10 西纳福克斯股份有限公司 (杂)芳基1,3‑偶极化合物与(杂)环炔的环加成方法
EP3160513B1 (en) 2014-06-30 2020-02-12 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
EP4148138A1 (en) 2014-08-04 2023-03-15 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
PT3134520T (pt) 2015-04-23 2018-03-26 Synaffix Bv Resumo
JP2019501663A (ja) 2016-01-15 2019-01-24 ユニバーシティー オブ メリーランド,カレッジ パーク グリコシンターゼとしてのEndo−S2変異体、糖タンパク質の製造方法および糖タンパク質の糖鎖操作のための使用
JP7123801B2 (ja) 2016-02-04 2022-08-23 ジェノビス エービー 新しい連鎖球菌プロテアーゼ
TWI727883B (zh) * 2016-08-24 2021-05-11 醣基生醫股份有限公司 利用醣苷內切酶突變體重塑醣蛋白及其使用方法
CN111183220B (zh) 2017-05-26 2024-03-22 杰诺维斯公司 用于聚糖分析的工具
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
JP2021528406A (ja) 2018-06-19 2021-10-21 グリコス バイオメディカル オーワイ コンジュゲート
CN112672765A (zh) 2018-06-29 2021-04-16 格莱科斯生物医药公司 结合物
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
AU2021205312A1 (en) 2020-01-09 2022-07-14 Mersana Therapeutics, Inc. Site specific antibody-drug conjugates with peptide-containing linkers
WO2022057942A1 (zh) * 2020-09-21 2022-03-24 上海宝济药业有限公司 一种药物组合及其应用
JP2024501894A (ja) 2021-01-04 2024-01-16 メルサナ セラピューティクス インコーポレイテッド B7h4ターゲティング抗体-薬物コンジュゲートおよびその使用方法
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
WO2009033670A2 (en) 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
WO2011039150A1 (en) * 2009-10-02 2011-04-07 Roche Glycart Ag A-fucosylation detection in antibodies

Also Published As

Publication number Publication date
GB201115841D0 (en) 2011-10-26
EA201490447A1 (ru) 2014-09-30
EA028490B1 (ru) 2017-11-30
US20140302519A1 (en) 2014-10-09
SG11201400505YA (en) 2014-04-28
EA028490B8 (ru) 2018-01-31
KR20140081813A (ko) 2014-07-01
EP2756077A1 (en) 2014-07-23
BR112014005816A2 (pt) 2020-12-29
MX2014002906A (es) 2014-10-17
DK2756077T3 (en) 2017-07-03
US9493752B2 (en) 2016-11-15
CN103946377A (zh) 2014-07-23
WO2013037824A1 (en) 2013-03-21
GB2509284A (en) 2014-06-25
KR102001427B1 (ko) 2019-07-18
JP6076349B2 (ja) 2017-02-08
CA2848230A1 (en) 2013-03-21
JP2014531205A (ja) 2014-11-27
PL2756077T3 (pl) 2017-09-29
MX347727B (es) 2017-05-10
GB201406321D0 (en) 2014-05-21
CN103946377B (zh) 2016-10-05
CA2848230C (en) 2020-03-24
ES2627334T3 (es) 2017-07-27
NZ622172A (en) 2016-04-29
EP2756077B1 (en) 2017-03-29
IL231410A0 (en) 2014-04-30
PT2756077T (pt) 2017-06-21
AU2012307461A1 (en) 2014-03-27
ZA201401840B (en) 2018-05-30
AU2012307461B2 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
IN2014CN02163A (es)
NZ702962A (en) Agse-deficient strain
WO2012125937A3 (en) Glycosyl hydrolase enzymes and uses thereof for biomass hydrolysis
MX2015000844A (es) Cepa con deficit de amilasa.
PH12016500377A1 (en) Polypeptide for the hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof, and additive containing polypeptide, use of said polypeptide and method
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
NZ616035A (en) Compositions relating to a mutant clostridium difficile toxin and methods thereof
NZ725398A (en) Variants of chymosin with improved milk-clotting properties
MY171544A (en) A cell with reduced ppgppase activity
EA201300876A1 (ru) Мутантная целлобиогидролаза
NZ731727A (en) Method for producing a protein hydrolysate
EP4374913A3 (en) Novel human serum albumin mutant
WO2012009026A3 (en) Novel methods of protein evolution
WO2010101359A3 (ko) L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산 방법
MX2017007105A (es) Variantes de lipasa y polinucleotidos que las codifican.
MX365947B (es) Operaciones de cosecha mejoradas para proteinas recombinadas.
MY159439A (en) Method for producing glucosidase, enzyme composition, and method for hydrolyzing biomass
AU2015344324A8 (en) Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution
MX2012000532A (es) Procesamiento de anticuerpo enzimatico.
NZ707753A (en) Purification of recombinant human galactocerebroside β-galactosidase (rhgalc)
SG182006A1 (en) Trichoderma viride strain for cellulolytic enzyme production
EA033091B1 (ru) ПШЕНИЦА С НОВЫМИ АЛЛЕЛЯМИ Rht-B1
WO2009129086A3 (en) Endoglycosidases that cleave o-linked glycans
WO2011124925A3 (en) Polysaccharide degrading enzymes from coleoptera
WO2010146555A3 (en) Automatic setting system for mosaic